Current research studies
A summary of current research studies.
RAPID2
A hip fracture is an exceedingly painful injury and pain relief given by a paramedic usually includes morphine. This may not always work very well and can lead to side effects, such as confusion. In the RAPID2 study, paramedics may give a local anaesthetic injection (known as fascia iliaca compartment block or FICB) to patients with an injured hip before they are transported to hospital. Giving this injection may provide better pain control and better long-term outcomes than the alternatives currently in use.
The aim of RAPID2 is to test the safety, and effectiveness of paramedics providing FICB pain relief to patients with suspected hip fracture prior to hospitalisation.
This patient notification contains further patient information about the RAPID2 research trial: Read the RAPID2 patient notification.
Study website: RAPID2
Study protocol: Clinical and cost-effectiveness of paramedic administered FICB for emergency hip fracture (RAPID 2)
CRASH-4
The CRASH-4 trial aims to provide reliable evidence about the effects of early intramuscular tranexamic acid on intracranial haemorrhage, disability, death and dementia in older adults with symptomatic mild head injury.
Study website: CRASH 4 Trial
Pilot Study findings: CRASH 4 Trial - Pilot Study
PARAMEDIC-3
The University of Warwick is working with ambulance services to study how best to give people life-saving medications if their heart suddenly stops (they have a cardiac arrest). If your family member had a cardiac arrest and was treated by the East of England Ambulance Service, they may have been included in this study.
If you would like more information about this study, please contact the PARAMEDIC3 study team:
- Telephone: 024 765 72905
- Email: paramedic3@warwick.ac.uk
- Visit: www.warwick.ac.uk/paramedic3
Study protocol: PARAMEDIC3 - Protocol
EVOLVED
The main aims of the EVOLVED study (Factors impacting vitamin D in ambulance staff) are to explore the behaviours and lifestyle factors of VITALS participants whose Vitamin D levels were sufficient or insufficient; to understand the work and personal impacts of vitamin D levels on VITALS participants and to explore suggested ways that staff wellbeing could be improved through vitamin D-related interventions.